Subscribe to Newsletter

January 2014 Issue of The Ophthalmologist

Register to download
Register here to download any issue of The Ophthalmologist for FREE.
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Profession Basic & Translational Research

Cost: The Final Frontier

| Mark Hillen

Gene therapy for ocular disease will soon be available. Stem cell therapies too. They may be able to cure the currently untreatable, but at what price? And will anyone pay it?

Subspecialties Basic & Translational Research

Keeping an Eye on Diabetes

| Mark Hillen

Transplanting pancreatic Islets of Langerhans into the ocular anterior chamber of the eye allows researchers to effectively monitor ?-cell function.

Business & Profession Retina

20/200 Drivers

| Mark Hillen

Americans love their cars and in many places you’re virtually stranded if you don’t drive. So does vision loss stop elderly Americans from driving?

Subspecialties Cornea / Ocular Surface

Dropper Bother

| Mark Hillen

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) issues a safety alert for Cosopt preservative-free single-dose eye drops

Subspecialties Imaging & Diagnostics

Retinal Visualization of Schizophrenia

| Mark Hillen

OCT imaging visualizes retinal nerve fiber layers and the thickness of the macula; abnormalities in either can predict the stage and duration of schizophrenia.

Business & Profession Other

Will Eye Bling Take Off?

| Mark Hillen

The media have been building up “eyeball jewelry” as a potential craze, but the evidence suggests otherwise

Subspecialties Professional Development

Not All Big Pharma Loves Ophtho

| Mark Hillen

While other pharmaceutical companies are buying into ophthalmology, Pfizer is heading for the hills

Business & Profession Cornea / Ocular Surface

Seeing What’s Behind the Camera

| Mark Hillen

The pupil of the eye is dark, and the cornea highly reflective – it acts as a mirror. Combine this with high resolution photography, and you get a whole new vista.

Subspecialties Retina

VEGF has Physiolgical as well as Pathological Functions

| Magali Saint-Geniez and Patricia D’Amore

Growing evidence for the key role played by VEGF in the normal adult eye now demands that ophthalmologists give careful consideration to the use of anti-VEGF therapies.

Subspecialties Cornea / Ocular Surface

DMEK Simplified, Deftly

| Marc Muraine

A novel method for preparation of Descemet membrane endothelial keratoplasty (DMEK) grafts is here. It uses a punch but doesn’t lay a finger (or forceps) on the corneal endothelial cells.

Subspecialties Cataract

Ten Tips for Toric Lens Implantation

| David Kent

Practical pearls and possible pitfalls for the general cataract surgeon

Subspecialties Cornea / Ocular Surface

A Novel Refractive Procedure for Keratoconus

| Francisco Sánchez León

Intracorneal ring segment and phakic IOL implantation: a refractive solution for patients with keratoconus and high myopia

Business & Profession Basic & Translational Research

Gene Therapy Clinical Trials

| Irv Arons, Mark Hillen

The EMA approved the first gene therapy agent in 2012 – for lipoprotein lipase deficiency. Might gene therapies for ophthalmic disease reach the wards any time soon?

Subspecialties Retina

Integrin Blockade as a Retinovascular Therapy

| David Boyer

A new drug, ALG-1001, that blocks the transmembrane receptors that cells use to attach to their surroundings, has the potential to treat a range of retinovascular diseases

Business & Profession Professional Development

Re-engineering Healthcare

| Jim Taylor

For all of us associated with healthcare, it should be apparent that our world is on the cusp of a significant change.

Business & Profession Professional Development

Six Strategies to Stimulate Resident Learning

| Karl Golnik

Academic ophthalmologists are expected to be effective teachers but receive little or no instruction on teaching methodology.

Business & Profession Professional Development

Right place, right time

Sitting Down With Carrie MacEwen, Consultant Ophthalmologist at Ninewells Hospital, Dundee, Scotland, and President-Elect of the UK Royal College of Ophthalmologists

Business & Profession Other

The Ophthalmologist Power List 2014

| Richard Gallagher

Ranking the 100 most influential people in ophthalmology. Which clinicians and researchers have the biggest impact on our field?

Other issues of 2014


The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: